Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,840 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies.
Takahashi M, Ai T, Sinozuka K, Baba Y, Igawa G, Nojiri S, Yamamoto T, Yuri M, Takei S, Saito K, Horiuchi Y, Kanno T, Tobiume M, Khasawneh A, Paran FJ, Hiki M, Wakita M, Miida T, Suzuki T, Okuzawa A, Takahashi K, Naito T, Tabe Y. Takahashi M, et al. Among authors: takahashi k. Sci Rep. 2022 Sep 1;12(1):14909. doi: 10.1038/s41598-022-19073-z. Sci Rep. 2022. PMID: 36050347 Free PMC article.
Comparison of the Analytical Performance Between cobas EGFR Assay and PCR-Clamp Method in the Detection of EGFR Mutations in Japanese Non-Small Cell Lung Cancer Patients.
Ai T, Yuri M, Tabe Y, Kakimoto A, Morishita S, Tsuchiya K, Takamochi K, Kodama Y, Takahashi F, Shigeki M, Horii T, Suzuki K, Takahashi K, Miida T, Ohsaka A. Ai T, et al. Among authors: takahashi k, takahashi f. Clin Lab. 2017 May 1;63(5):1021-1026. doi: 10.7754/Clin.Lab.2017.161223. Clin Lab. 2017. PMID: 28627833
Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests.
Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, Yamamoto T, Igawa G, Hinata M, Kadota K, Kurosawa T, Takahashi S, Saito T, Misawa S, Akazawa C, Naito T, Miida T, Takahashi K, Ai T, Tabe Y. Wakita M, et al. Among authors: takahashi k, takahashi s. PLoS One. 2021 Feb 8;16(2):e0246536. doi: 10.1371/journal.pone.0246536. eCollection 2021. PLoS One. 2021. PMID: 33556086 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, Matsushita Y, Matsushita M, Wakita M, Misawa S, Idei M, Miida T, Tamura N, Takahashi K, Naito T. Hiki M, et al. Among authors: takahashi k. PLoS One. 2021 Apr 6;16(4):e0249449. doi: 10.1371/journal.pone.0249449. eCollection 2021. PLoS One. 2021. PMID: 33822809 Free PMC article. Clinical Trial.
SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo.
Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C, Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida T, Sato H, Hattori N, Tabe Y, Takahashi K. Fukuda H, et al. Among authors: takahashi k. Sci Rep. 2021 Apr 16;11(1):8380. doi: 10.1038/s41598-021-87688-9. Sci Rep. 2021. PMID: 33863960 Free PMC article.
16,840 results
You have reached the last available page of results. Please see the User Guide for more information.